We employ the epidemic Renormalization Group (eRG) framework to understand, reproduce and predict the COVID-19 pandemic diffusion across the US. The human mobility across different geographical US divisions is modelled via open source flight data alongside the impact of social distancing for each such division. We analyse the impact of the vaccination strategy on the current pandemic wave dynamics in the US. We observe that the ongoing vaccination campaign will not impact the current pandemic wave and therefore strict social distancing measures must still be enacted. To curb the current and the next waves our results indisputably show that vaccinations alone are not enough and strict social distancing measures are required until sufficient immunity is achieved. Our results are essential for a successful vaccination strategy in the US.
The dynamics of epidemics depend on how peoples behavior changes during an outbreak. The impact of this effect due to control interventions on the morbidity rate is obvious and supported by numerous studies based on SIR-type models. However, the existing models do not explain the difference in outbreak profiles in countries with different intrinsic socio-cultural features and are rather specific for describing the complex dynamics of an outbreak. A system of models of the COVID-19 pandemic is proposed, combining the dynamics of social stress described by the tools of sociophysics8 with classical epidemic models. Even the combination of a dynamic SIR model with the classic triad of stages of general adaptation syndrome, Alarm-Resistance-Exhaustion, makes it possible to describe the available statistics for various countries of the world with a high degree of accuracy. The conceptualization of social stress leads to the division of the vulnerable population into different groups according to behavior mode, which can be tracked in detail. The sets of kinetic constants corresponding to optimal fit of model to data clearly characterize the society ability to focus efforts on protection against pandemic and keep this concentration for a considerable time. Such characterization can further help in the development of management strategies specific to a particular society: country, region, or social group.
Since the end of 2019, COVID-19 has significantly affected the lives of people around the world. Towards the end of 2020, several COVID-19 vaccine candidates with relatively high efficacy have been reported in the final phase of clinical trials. Vaccines have been considered as critical tools for opening up social and economic activities, thereby lessening the impact of this disease on the society. This paper presents a simulation of COVID-19 spread using modified Susceptible-Infected-Removed (SIR) model under vaccine intervention in several localities of Malaysia, i.e. those cities or states with high relatively COVID-19 cases such as Kuala Lumpur, Penang, Sabah, and Sarawak. The results show that at different vaccine efficacy levels (0.75, 0.85, and 0.95), the curves of active infection vary slightly, indicating that vaccines with efficacy above 0.75 would produce the herd immunity required to level the curves. In addition, disparity is significant between implementing or not implementing a vaccination program. Simulation results also show that lowering the reproduction number, R0 is necessary to keep the infection curve flat despite vaccination. This is due to the assumption that vaccination is mostly carried out gradually at the assumed fixed rate. The statement is based on our simulation results with two values of R0: 1.1 and 1.2, indicative of reduction of R0 by social distancing. The lower R0 shows a smaller peak amplitude about half the value simulated with R0=1.2. In conclusion, the simulation model suggests a two-pronged strategy to combat the COVID-19 pandemic in Malaysia: vaccination and compliance with standard operating procedure issued by the World Health Organization (e.g. social distancing).
We study the epidemic spreading on spatial networks where the probability that two nodes are connected decays with their distance as a power law. As the exponent of the distance dependence grows, model networks smoothly transition from the random network limit to the regular lattice limit. We show that despite keeping the average number of contacts constant, the increasing exponent hampers the epidemic spreading by making long-distance connections less frequent. The spreading dynamics is influenced by the distance-dependence exponent as well and changes from exponential growth to power-law growth. The observed power-law growth is compatible with recent analyses of empirical data on the spreading of COVID-19 in numerous countries.
Several European countries have suspended the inoculation of the AstraZeneca vaccine out of suspicion of causing deep vein thrombosis. In this letter we report some Fermi estimates performed using a stochastic model aimed at making a risk-benefit analysis of the interruption of the delivery of the AstraZeneca vaccine in France and Italy. Our results clearly show that excess deaths due to the interruption of the vaccination campaign injections largely overrun those due to thrombosis even in worst case scenarios of frequency and gravity of the vaccine side effects.
We present results of different approaches to model the evolution of the COVID-19 epidemic in Argentina, with a special focus on the megacity conformed by the city of Buenos Aires and its metropolitan area, including a total of 41 districts with over 13 million inhabitants. We first highlight the relevance of interpreting the early stage of the epidemic in light of incoming infectious travelers from abroad. Next, we critically evaluate certain proposed solutions to contain the epidemic based on instantaneous modifications of the reproductive number. Finally, we build increasingly complex and realistic models, ranging from simple homogeneous models used to estimate local reproduction numbers, to fully coupled inhomogeneous (deterministic or stochastic) models incorporating mobility estimates from cell phone location data. The models are capable of producing forecasts highly consistent with the official number of cases with minimal parameter fitting and fine-tuning. We discuss the strengths and limitations of the proposed models, focusing on the validity of different necessary first approximations, and caution future modeling efforts to exercise great care in the interpretation of long-term forecasts, and in the adoption of non-pharmaceutical interventions backed by numerical simulations.